Haystack is looking forward to attending the ASCO Gastrointestinal Cancers Annual Symposium taking place January 19-21 in San Francisco, CA. ASCO GI will be celebrating 20 years of offering the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. If you’re there, please stop by table #43 and learn about Haystack’s MRD test that delivers unmatched ctDNA detection sensitivity and accuracy for superior post-surgical treatment management.
Select providers now have access to Haystack MRD® via OncoEMR MPI capability
July 9, 2026
We are excited to announce the launch of a pilot program between Haystack MRD® by Quest Diagnostics® and OncoEMR! Select providers now have access to Haystack MRD via OncoEMR MPI capability – meaning that you may be able to order
